A February filing shows that Representative French Hill reported a sale in CVS Health CVS, valued between $15,001 and $50,000. The transaction date is listed as February 4, 2025, with the report published on February 4, 2025.
At present, CVS Health shares are trading up 0.27% at $56.5.
Representative's Recent Trading Activity
Over the past three years, French Hill executed 16 trades totaling over $444 thousand. The largest of these trades were in Philip Morris Intl and Altria Group stock. Some of the key transactions the Rep. has executed recently include: None
Here is a list of French Hill's most recent trades:
Stay informed on French Hill's trades and other members of Congress with our real-time government trades tracking tool!
The Importance of Congressional Transactions
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
Why Congressional Transactions Matter
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.